Filing Details

Accession Number:
0001181431-14-023211
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-06 20:49:23
Reporting Period:
2014-06-04
Filing Date:
2014-06-06
Accepted Time:
2014-06-06 19:49:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386858 Hyperion Therapeutics Inc HPTX Pharmaceutical Preparations (2834) 611512713
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202793 Michael Powell C/O Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1362314 Eric Buatois C/O Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1380734 P L Vii Partners Venture Sofinnova C/O Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1421501 Sofinnova Management Vii, L.l.c. C/O Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-04 417,747 $27.70 1,939,474 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares are owned directly by Sofinnova Venture Partners VII, L.P. ( "SV VII"). Sofinnova Management VII, L.L.C. ("SV VII LLC"), the general partner of SV VII, and James Healy, a director of the Issuer, Michael Powell, and Eric Buatois, the managing members of SV VII LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV VII. Such persons and entities disclaim beneficial ownership over the shares owned by SV VII except to the extent of any pecuniary interest therein.